Status:
NOT_YET_RECRUITING
Evaluation of Serum IL-7 as a Biomarker in Breast Cancer
Lead Sponsor:
Assiut University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Breast cancer is one of the most commonly diagnosed cancers and leading cause of cancer-related mortality in women worldwide, posing a serious threat to their health (1). It is a heterogeneous diseas...
Eligibility Criteria
Inclusion
- Female patients diagnosed with Breast cancer based on pathological and radiological confirmation.
- Age \> 18
Exclusion
- Male
- Patients diagnosed with other malignant diseases
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT07133685
Start Date
September 1 2025
End Date
December 1 2026
Last Update
August 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.